Skip to content

Clinical trials

Bronchiectasis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiectasis Country / region: China Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20124
20132
20144
20153
20164
20172
20185
20193
20202
20214
20222
20237
20247
202512
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status24
Recruiting18
Completed16
Not yet recruiting3
Active, not recruiting2
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Pulmonary Hospital, Shanghai, China13
Guangzhou Institute of Respiratory Disease5
Ruijin Hospital5
The First Affiliated Hospital of Guangzhou Medical University5
First Affiliated Hospital of Ningbo University4
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology4
Qianfoshan Hospital3
Jin-Fu Xu2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Shanghai University of Traditional Chinese Medicine2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiectasis65
Pulmonary Disease, Chronic Obstructive10
Asthma6
Pseudomonas Infections4
Anxiety Disorders2
Aspergillosis, Allergic Bronchopulmonary2
Bronchitis2
Cystic Fibrosis2
Hypertension, Pulmonary2
Lung Diseases, Interstitial2

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.